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Quality byTest (QbT) was the only way to guarantee the quality
of drug products before FDA launches current Good Manufac-
turing Practice (cGMP) [1], which is an approach without clear
understanding of the processes. In order to solve this problem,
FDA generalized Quality by Design (QbD) in the field of phar-
macy [2]. In pharmaceutical industry, QbD brings cost-efficiency
and simplicity of manufacturing process into reality. Several
tools are utilized to make QbD system easily applied to phar-
maceutical field, namely design of experiment (DoE), risk
assessment and process analytical technology (PAT). QbD is
based on the thorough understanding of how materials and
process parameters affect the profile of final products.The fol-
lowing parameters are defined to describe those characteristics:
Quality target product profile (QTPP); critical quality attri-
butes (CQAs); critical material attributes (CMAs) and critical
process parameters (CPPs) [3].
The applications of DoE and PAT in pharmaceutical field are
discussed in detail in this review. DoE combines parameters
such as CPPs, CMAs and CQAs into QbD system, which is a rea-
sonable method to determine the relationship between the
input and output of a process. In addition, full factorial design,
Plackett–Burman (PB) screening design, fractional factorial sta-
tistical design, central composite–face centered–response
surface design and Box–Behnken design can be used to es-
tablish a design space (DS) for a given process to guarantee
the quality of final products. In addition to DoE, PAT is also an
important tool of QbD; by obtaining technological and mate-
rial parameters online, it plays a role in real-time monitoring
of pharmaceutical process without interruption. In order to
achieve successful PAT implementation, there are three-step-
process (namely design, analyze and control) and four PAT tools
in the design and optimization of drug formulations andmanu-
facturing process; the four PAT tools are as follows: (1)
multivariate tools for design, data acquisition and analysis; (2)
process analyzers; (3) process control tools; and (4) continu-
ous improvement and knowledge management tools. In
conclusion, with the assistance of DoE and PAT together with
other QbD tools, thorough understanding of pharmaceutical
process can be achieved and stable quality of products can be
assured.
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Fig. 1 Comparison between QbT and QbD.
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